Mostrar el registro sencillo del ítem

Number of botulinum toxin injections needed to stop requests for treatment for chronic lateral epicondylar tendinopathy. A 1-year follow-up study

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorCOGNE, Melanie
dc.contributor.authorCREUZE, Alexandre
dc.contributor.authorPETIT, Herve
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDELLECI, Claire
IDREF: 132650967
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDEHAIL, Patrick
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDE SEZE, Mathieu
dc.date.accessioned2020-06-15T10:18:08Z
dc.date.available2020-06-15T10:18:08Z
dc.date.issued2019-09
dc.identifier.issn1877-0657en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/7919
dc.description.abstractEnBACKGROUND: Epicondylar tendinopathy ("tennis elbow") is a serious issue in manual labourers. Symptoms can persist over months or even more than 1 year, even when treated with trinitrine patches, acupuncture, sclerosis of neovessels, shock-wave therapy, autologous blood injections, platelet-rich plasma or hyaluronic acid. Botulinum toxin (BoNT-A) injections showed promising short-term results, but the long-term beneficial effects are not yet known. OBJECTIVE: We aimed to assess the long-term effect, side effects and recurrence rate after BoNT-A injections on chronic lateral epicondylar tendinopathy during 1 year. METHODS: This open study followed a 3-month randomized controlled trial. We included 50 patients followed at day 0 (V0), 90 (V1), 180-270 (V2) and 365 (V3). The main judgment criterion was the number of BoNT-A injections required to achieve pain relief with no further request for treatment by the patient. RESULTS: After one BoNT-A injection, 22/50 (44%) patients did not ask for further treatment during follow-up because of complete pain relief, and 20/50 (40%) asked for a second BoNT-A injection. For 20 patients with a second injection, 18 (90%) did not ask for further treatment during follow-up. Only 1 patient had a recurrence of pain after an initial pain relief of greater than 75%. Quality of life, and painful and maximal gripping force improved significantly at V1, V2 and V3 as compared with V0, and repercussions on daily and professional activities decreased significantly (P<0.05). CONCLUSIONS: One or 2 BoNT-A injections has favourable results for chronic epicondylar tendinopathy.
dc.language.isoENen_US
dc.subject.enHACS
dc.title.enNumber of botulinum toxin injections needed to stop requests for treatment for chronic lateral epicondylar tendinopathy. A 1-year follow-up study
dc.title.alternativeAnn Phys Rehabil Meden_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.rehab.2018.12.003en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed30639581en_US
bordeaux.journalAnnals of Physical and Rehabilitation Medicineen_US
bordeaux.page336-341en_US
bordeaux.volume62en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue5en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03210789
hal.version1
hal.date.transferred2021-04-28T08:32:25Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Annals%20of%20Physical%20and%20Rehabilitation%20Medicine&amp;rft.date=2019-09&amp;rft.volume=62&amp;rft.issue=5&amp;rft.spage=336-341&amp;rft.epage=336-341&amp;rft.eissn=1877-0657&amp;rft.issn=1877-0657&amp;rft.au=COGNE,%20Melanie&amp;CREUZE,%20Alexandre&amp;PETIT,%20Herve&amp;DELLECI,%20Claire&amp;DEHAIL,%20Patrick&amp;rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem